Kidney Injury Biomarker Assessment

Albuminuria was assessed by ELISA according to the manufacturer’s instructions (Bethyl Laboratories, Inc., Montgomery, TX, United States) (Watson et al., 2012 (link)).
Cystatin C (BioVendor – Laboratorni medicina a.s., Karasek, Brno, Czech Republic) and KIM-1 (kidney injury molecule-1, or hepatitis A virus cellular receptor 1; Assay Matrix; EIAab, Optics Valley, Wuhan, China) ELISA analyses were carried out on plasma samples as per the manufacturer’s instructions.

Free full text: Click here

Watson A.M., Gould E.A., Penfold S.A., Lambert G.W., Pratama P.R., Dai A., Gray S.P., Head G.A, & Jandeleit-Dahm K.A. (2019). Diabetes and Hypertension Differentially Affect Renal Catecholamines and Renal Reactive Oxygen Species. Frontiers in Physiology, 10, 309.

Publication 2019

ELISA Cystatin C

Assay Cystatin c Elisa Hepatitis a virus cellular receptor 1 Optics Plasma

Corresponding Organization : Baker Heart and Diabetes Institute

Other organizations : Swinburne University of Technology

Top 5 similar protocols

Variable analysis

independent variables

Albuminuria
Cystatin C
KIM-1 (kidney injury molecule-1, or hepatitis A virus cellular receptor 1)

dependent variables

Albuminuria
Cystatin C
KIM-1 (kidney injury molecule-1, or hepatitis A virus cellular receptor 1)

control variables

Plasma samples

controls

Positive controls: Not specified
Negative controls: Not specified

Annotations

Based on most similar protocols

Etiam vel ipsum. Morbi facilisis vestibulum nisl. Praesent cursus laoreet felis. Integer adipiscing pretium orci. Nulla facilisi. Quisque posuere bibendum purus. Nulla quam mauris, cursus eget, convallis ac, molestie non, enim. Aliquam congue. Quisque sagittis nonummy sapien. Proin molestie sem vitae urna. Maecenas lorem.

As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Revolutionizing how scientists
search and build protocols!